Influenza virus resistance to antiviral agents: a plea for rational use.

No abstract is available for this paper.

• Publication year

  2009

• Venue

  Clinical Infectious Diseases

• Publication date

  2009-05-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1086/598989PMID 19323631PMCID PMC2831648
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Oseltamivir-Resistant Influenza Viruses A (H1N1), Norway, 2007–08

  2009cited by this paper
• Neuraminidase inhibitor resistance after oseltamivir treatment of acute influenza A and B in children.

  2009cited by this paper
• Implications of antiviral resistance of influenza viruses.

  2009cited by this paper
• Developing new antiviral agents for influenza treatment: what does the future hold?

  2009cited by this paper
• Surveillance for Neuraminidase Inhibitor Resistance among Human Influenza A and B Viruses Circulating Worldwide from 2004 to 2008

  2008cited by this paper
• Detection of human influenza A (H1N1) and B strains with reduced sensitivity to neuraminidase inhibitors.

  2008cited by this paper
• Update: influenza activity--United States, September 28-November 29, 2008.

  2008cited by this paper
• Emergence of resistance to oseltamivir among influenza A(H1N1) viruses in Europe.

  2008cited by this paper
• Emergence of influenza B viruses with reduced sensitivity to neuraminidase inhibitors.

  2007cited by this paper
• Combination chemotherapy, a potential strategy for reducing the emergence of drug-resistant influenza A variants.

  2006cited by this paper
• Neuraminidase Inhibitor-Resistant and -Sensitive Influenza B Viruses Isolated from an Untreated Human Patient

  2006cited by this paper
• Adamantane resistance among influenza A viruses isolated early during the 2005-2006 influenza season in the United States.

  2006cited by this paper
• Recovery of drug-resistant influenza virus from immunocompromised patients: a case series.

  2006cited by this paper
• Antivirals for influenza in healthy adults: systematic review.

  2006cited by this paper
• Influenza Virus Susceptibility and Resistance to Oseltamivir

  2005cited by this paper
• Oseltamivir resistance during treatment of influenza A (H5N1) infection.

  2005cited by this paper
• Incidence of adamantane resistance among influenza A (H3N2) viruses isolated worldwide from 1994 to 2005: a cause for concern.

  2005cited by this paper
• Resistant influenza A viruses in children treated with oseltamivir: descriptive study.

  2004cited by this paper
• Management of influenza in households: a prospective, randomized comparison of oseltamivir treatment with or without postexposure prophylaxis.

  2004cited by this paper
• Safety and Efficacy of Nebulized Zanamivir in Hospitalized Patients with Serious Influenza

  2002cited by this paper
• Oral oseltamivir treatment of influenza in children

  2001cited by this paper
• Inhaled zanamivir for the prevention of influenza in families. Zanamivir Family Study Group.

  2000cited by this paper
• Influenza virus neuraminidase inhibitors.

  2000cited by this paper
• Emergence and transmission of influenza A viruses resistant to amantadine and rimantadine.

  1992cited by this paper
• Resistant influenza A viruses in children treated with oseltamivir : descriptive study

  year unknowncited by this paper

• Triethylamine inhibits influenza A virus infection and growth via mechanisms independent of viral neuraminidase and RNA-dependent RNA polymerase

  2025cites this paper
• SMCseeker: An attentive virtual screening model for antiviral discovery

  2025cites this paper
• Ceramide synthase 4 interferes with replication of influenza virus but is downregulated by infection

  2025cites this paper
• Hemagglutinin docking analysis-based visual detection of antiviral therapeutic efficacy of umifenovir against influenza virus.

  2025cites this paper
• Covalent Organic Framework-Based Theranostic Platforms for Restricting H1N1 Influenza Virus Infection

  2024cites this paper
• Targeted recruitment of immune effector cells for rapid eradication of influenza virus infections

  2024cites this paper
• Bakuchiol targets mitochondrial proteins, prohibitins and voltage-dependent anion channels: New insights into developing antiviral agents

  2024cites this paper
• Echinacea purpurea extract intervention for counteracting neurochemical and behavioral changes induced by bifenthrin

  2023cites this paper
• Intestinal Escherichia coli and related dysfunction as potential targets of Traditional Chinese Medicine for respiratory infectious diseases.

  2023cites this paper
• Advances in clinical development for vaccines and therapeutics against respiratory virus infections

  2023cites this paper
• An Efficient 4-Step Synthesis of Favipiravir with Industrial Potential

  2023cites this paper
• A five-day treatment course of zanamivir for the flu with a single, self-administered, painless microneedle array patch: Revolutionizing delivery of poorly membrane-permeable therapeutics.

  2023cites this paper
• In vitro and in vivo characterization of SARS-CoV-2 strains resistant to nirmatrelvir

  2023cites this paper
• Frequency and distribution of H1N1 influenza A viruses with oseltamivir‐resistant mutations worldwide before and after the 2009 pandemic

  2022cites this paper
• Porous gold nanoparticles for attenuating infectivity of in�uenza A virus

  2021cites this paper
• Chaiqin Qingning Capsule Inhibits Influenza Virus Infection and Inflammation In Vitro and In Vivo

  2021cites this paper
• Avian/Bird flu: A review: H5N1 outbreaks in Nepal

  2021cites this paper
• Organic synthesis and anti-influenza A virus activity of cyclobakuchiols A, B, C, and D

  2021cites this paper
• Influenza A virus NS1 induces degradation of sphingosine 1-phosphate lyase to obstruct the host innate immune response.

  2021cites this paper
• Targeting tumour necrosis factor to ameliorate viral pneumonia

  2021cites this paper
• A novel aqueous extract from rice fermented with Aspergillus oryzae and Saccharomyces cerevisiae possesses an anti-influenza A virus activity

  2021cites this paper
• Bioactive lead compounds and molecular targets for the treatment of heart disease.Phytochemicals as Lead Compounds for New Drug Discoverys

  2020cites this paper
• A molecularly engineered antiviral banana lectin inhibits fusion and is efficacious against influenza virus infection in vivo

  2020cites this paper
• The effects of age on clinical characteristics, hospitalization and mortality of patients with influenza‐related illness at a tertiary care centre in Malaysia

  2020cites this paper
• Antiviral phytocompounds for drug development

  2020cites this paper
• Porous gold nanoparticles for attenuating infectivity of influenza A virus

  2020cites this paper
• A cross-reactive human monoclonal antibody targets the conserved H7 antigenic site a from fifth wave H7N9-infected humans.

  2019cites this paper
• Antiviral activity of ethanol extract of Geranii Herba and its components against influenza viruses via neuraminidase inhibition

  2019cites this paper
• Design, synthesis and biological evaluation of amino acids-oleanolic acid conjugates as influenza virus inhibitors.

  2019cites this paper
• In vivo analysis of influenza A mRNA secondary structures identifies critical regulatory motifs

  2019cites this paper
• Transient inhibition of sphingosine kinases confers protection to influenza A virus infected mice

  2018cites this paper
• Energy Based Pharmacophore Modelling and Docking Studies for Determining Potent Inhibitor Against M2 Proton Channel of Influenza Virus

  2018cites this paper
• The Annexin A1 Receptor FPR2 Regulates the Endosomal Export of Influenza Virus

  2018cites this paper
• Assessing the benefits of early pandemic influenza vaccine availability: a case study for Ontario, Canada

  2018cites this paper
• Casein Kinase 1α Mediates the Degradation of Receptors for Type I and Type II Interferons Caused by Hemagglutinin of Influenza A Virus

  2018cites this paper
• Protein disulfide isomerases as potential therapeutic targets for influenza A and B viruses.

  2018cites this paper
• Effects of different principles of Traditional Chinese Medicine treatment on TLR7/NF-κB signaling pathway in influenza virus infected mice

  2018cites this paper
• The “New Public” and the “Good Ol’ Press”: Evaluating Online News Sources During the 2013 Polio Outbreak in Israel

  2017cites this paper
• Mucoadhesive Nanoparticles for Treatment of Influenza A

  2017cites this paper
• Double Plant Homeodomain Fingers 2 (DPF2) Promotes the Immune Escape of Influenza Virus by Suppressing Beta Interferon Production

  2017cites this paper
• Impact of H5N1 influenza virus infection on natural killer cells and innate lymphoid cell populations in macaques

  2017cites this paper
• In Vitro Antiviral Activity of Cinnamomum cassia and Its Nanoparticles Against H7N3 Influenza A Virus.

  2016cites this paper
• Antisense Oligonucleotides Targeting Influenza A Segment 8 Genomic RNA Inhibit Viral Replication

  2016cites this paper
• Antiviral drug resistance as an adaptive process

  2016cites this paper
• Influenza Viral Hemagglutinin Peptide Inhibits Influenza Viral Entry by Shielding the Host Receptor.

  2016cites this paper
• A high-throughput screening system targeting the nuclear export pathway via the third nuclear export signal of influenza A virus nucleoprotein.

  2016cites this paper
• Hemagglutinin of Influenza A Virus Antagonizes Type I Interferon (IFN) Responses by Inducing Degradation of Type I IFN Receptor 1

  2015cites this paper
• A monoclonal antibody binds to threonine 49 in the non-structural 1 protein of influenza A virus and interferes with its ability to modulate viral replication

  2015cites this paper
• Emergence and Pandemic Potential of Avian Influenza A (H7N9) Virus

  2015cites this paper
• Characterization of Potent Fusion Inhibitors of Influenza Virus

  2015cites this paper
• B Cells and Functional Antibody Responses to Combat Influenza

  2015cites this paper
• Progress on adenovirus-vectored universal influenza vaccines

  2015cites this paper
• Evaluation of vaccine efficacy in vitro using B cells: A valid approach?

  2015cites this paper
• The administration of oseltamivir results in reduced effector and memory CD8+ T cell responses to influenza and affects protective immunity

  2015cites this paper
• Inhibition of influenza virus infection and hemagglutinin cleavage by the protease inhibitor HAI-2.

  2014cites this paper
• A Broadly Neutralizing Human Monoclonal Antibody Directed against a Novel Conserved Epitope on the Influenza Virus H3 Hemagglutinin Globular Head

  2014cites this paper
• Profiling and characterization of potentially multidrug-resistant influenza neuraminidase 1 1 ( N 1 ) strains against neuraminidase inhibitors 2 3

  2014cites this paper
• Profiling and Characterization of Influenza Virus N1 Strains Potentially Resistant to Multiple Neuraminidase Inhibitors

  2014cites this paper
• Identification of a novel multiple kinase inhibitor with potent antiviral activity against influenza virus by reducing viral polymerase activity.

  2014cites this paper
• A novel method to produce Influenza A virus matrix protein M1 Capsid Like Particles (CLPs).

  2014cites this paper
• Differential and Conditional Activation of PKC-Isoforms Dictates Cardiac Adaptation during Physiological to Pathological Hypertrophy

  2014cites this paper
• In vitro activity of favipiravir and neuraminidase inhibitor combinations against oseltamivir-sensitive and oseltamivir-resistant pandemic influenza A (H1N1) virus

  2014cites this paper
• Synthesis, structure and inhibitory activity of a stereoisomer of oseltamivir carboxylate.

  2014cites this paper
• Antiviral activity of baicalin against influenza virus H1N1-pdm09 is due to modulation of NS1-mediated cellular innate immune responses.

  2014cites this paper
• neutralizing human monoclonal antibody directed against a novel conserved 3 epitope on the influenza virus H 3 hemagglutinin globular head 4 5

  2014cites this paper
• Dynamics of human influenza Vieng resistance to chemotherapeutic drugs from 2000 to 2009

  2014cites this paper
• Targeting host cell factors for development of antiviral therapeutics.

  2014cites this paper
• Human disease-behavior interactions on complex networks models :incorporating evolutionary game into epidemiology

  2014cites this paper
• Antimicrobial prophylaxis and outpatient management of fever and neutropenia in adults treated for malignancy: American Society of Clinical Oncology clinical practice guideline.

  2013cites this paper
• Antiviral therapy for the treatment and prophylaxis of influenza.

  2013cites this paper
• Characteristics of transplant recipients who developed influenza in 2007-08 despite influenza vaccination

  2013cites this paper
• Antiviral Drug Therapy- Exploiting Medicinal Plants

  2013cites this paper
• Inhibition of A/Human/Hubei/3/2005 (H3N2) influenza virus infection by silver nanoparticles in vitro and in vivo

  2013cites this paper
• Inhibition effect of alpha-lipoic acid on the propagation of influenza A virus in MDCK cells.

  2012cites this paper
• Improving influenza virus detection.

  2012cites this paper
• [A study on the standard of influenza neuraminidase inhibition assay].

  2012cites this paper
• INFLUENZA A (H1N1) AND THE RESISTANCE TO OSELTAMIVIR

  2012cites this paper
• randomized placebo-controlled trial.

  2012cites this paper
• Influenza viruses: an introduction.

  2012cites this paper
• Oseltamivir in Seasonal , Avian H 5 N 1 and Pandemic 2009 A / H 1 N 1 Influenza Pharmacokinetic and Pharmacodynamic Characteristics

  2012cites this paper
• Mixed results from combination therapy

  2011cites this paper
• Parasite-Mediated Upregulation of NK Cell-Derived Gamma Interferon Protects against Severe Highly Pathogenic H5N1 Influenza Virus Infection

  2011cites this paper
• Effective multi-strain inhibition of influenza virus by anionic gold nanoparticles

  2011cites this paper
• Life-Threatening Viral Diseases and Their Treatment

  2011cites this paper
• Targeting B cell responses in universal influenza vaccine design.

  2011cites this paper
• Influenzavirus A/H1N1/2009 – ein Überblick vom Ausbruch bis zur Vakzination

  2011cites this paper
• The regulation of lung homeostasis and influenza-associated inflammation

  2011cites this paper
• Adenovirus-Vectored Drug-Vaccine Duo as a Rapid-Response Tool for Conferring Seamless Protection against Influenza

  2011cites this paper
• The Ras–PI3K Signaling Pathway Is Involved in Clathrin-Independent Endocytosis and the Internalization of Influenza Viruses

  2011influential citation
• Clinical manifestations, therapy and outcome of pandemic influenza A (H1N1) 2009 in hospitalized patients.

  2011cites this paper
• Several generations of chemoenzymatic synthesis of oseltamivir (Tamiflu): evolution of strategy, quest for a process-quality synthesis, and evaluation of efficiency metrics.

  2011cites this paper
• Adenovirus-vectored drug–vaccine duo as a potential driver for conferring mass protection against infectious diseases

  2011cites this paper
• Detection of Resistance Mutations to Antivirals Oseltamivir and Zanamivir in Avian Influenza A Viruses Isolated from Wild Birds

  2011cites this paper
• Human Monoclonal Antibodies for Prophylaxis and Treatment of Influenza

  2011cites this paper
• 3 Pulmonary opportunistic infections

  2011cites this paper
• Environmental Levels of the Antiviral Oseltamivir Induce Development of Resistance Mutation H274Y in Influenza A/H1N1 Virus in Mallards

  2011cites this paper
• Applications of the Phytomedicine Echinacea purpurea (Purple Coneflower) in Infectious Diseases

  2011cites this paper
• Differences in clinical outcomes after 2009 influenza A/H1N1 and seasonal influenza among hematopoietic cell transplant recipients.

  2011cites this paper
• How I treat influenza in patients with hematologic malignancies.

  2010cites this paper
• Advances in the vaccination of the elderly against influenza: role of a high-dose vaccine

  2010cites this paper